New announcement. Learn more

Key messages for the public funding of Emgality (galcanezumab)

Our Key Messages are grouped to match Pharmac's 4 Factors for Consideration for funding decisions: Health Need, Health Benefits, Suitability, and Costs & Savings

You can also download a PDF version of the Key Messages below.